Sam-A Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14,672	6,580	9,551	9,019	9,176	7,984
Short-Term Investments	31,100	39,602	48,638	61,638	68,638	45,638
Trading Asset Securities	56,413	51,460	18,474	8,447	3,197	-
Cash & Short-Term Investments	102,186	97,642	76,664	79,104	81,011	53,623
Cash Growth	20.99%	27.36%	-3.08%	-2.35%	51.08%	-16.68%
Accounts Receivable	17,286	19,468	19,060	22,596	21,466	18,039
Other Receivables	1,961	2,081	2,794	3,079	2,025	1,293
Receivables	20,124	21,548	21,854	25,675	23,491	19,332
Inventory	15,332	16,468	14,283	13,013	12,244	9,341
Prepaid Expenses	-	207.19	135.22	160.76	71.14	44.88
Other Current Assets	279.03	2.96	153.46	38.37	40.27	13.96
Total Current Assets	137,921	135,869	113,089	117,992	116,856	82,355
Property, Plant & Equipment	38,249	39,173	42,750	40,511	37,164	40,188
Long-Term Investments	49,320	50,141	71,939	61,362	42,957	60,434
Other Intangible Assets	4,661	4,641	4,189	4,295	4,394	5,537
Long-Term Deferred Tax Assets	420.53	420.53	519.39	80.27	1,041	-
Other Long-Term Assets	17,546	6,938	6,819	7,067	786.49	657.77
Total Assets	248,117	247,045	248,734	231,308	203,198	189,172
Accounts Payable	3,885	4,178	5,830	5,002	7,040	3,772
Accrued Expenses	-	1,360	907.14	2,229	1,745	15.74
Current Portion of Long-Term Debt	1,139	2,278	4,556	1,667	-	2,407
Current Portion of Leases	1,810	1,820	1,835	1,858	1,725	1,709
Current Income Taxes Payable	727.76	233.33	3,721	3,542	4,386	1,580
Other Current Liabilities	10,143	4,022	3,659	6,847	6,662	5,111
Total Current Liabilities	17,705	13,891	20,508	21,145	21,558	14,594
Long-Term Debt	-	-	2,278	2,500	-	-
Long-Term Leases	2,460	2,844	4,221	5,645	45	1,509
Pension & Post-Retirement Benefits	65.83	43.42	82.87	-	-	-
Long-Term Deferred Tax Liabilities	-	-	18.24	12.05	12.05	175.08
Other Long-Term Liabilities	1,994	2,155	1,650	1,536	964.81	868.76
Total Liabilities	22,225	18,934	28,758	30,838	22,580	17,147
Common Stock	6,370	6,370	6,370	6,370	6,370	6,370
Additional Paid-In Capital	14,413	14,413	14,413	14,413	14,413	14,413
Retained Earnings	201,209	204,168	196,482	179,204	160,354	149,836
Treasury Stock	-	-1,513	-1,513	-1,513	-1,513	-1,513
Comprehensive Income & Other	3,900	4,673	4,223	1,996	992.92	2,917
Shareholders' Equity	225,893	228,111	219,976	200,470	180,618	172,024
Total Liabilities & Equity	248,117	247,045	248,734	231,308	203,198	189,172
Total Debt	5,409	6,942	12,890	11,669	1,770	5,625
Net Cash (Debt)	96,777	90,700	63,774	67,435	79,241	47,998
Net Cash Growth	32.48%	42.22%	-5.43%	-14.90%	65.09%	-16.01%
Net Cash Per Share	15854.54	14860.70	10450.12	11048.85	12983.19	7864.24
Filing Date Shares Outstanding	6.11	6.1	6.1	6.1	6.1	6.1
Total Common Shares Outstanding	6.11	6.1	6.1	6.1	6.1	6.1
Working Capital	120,216	121,977	92,581	96,848	95,298	67,761
Book Value Per Share	36978.43	37374.73	36041.86	32845.97	29593.28	28185.26
Tangible Book Value	221,231	223,470	215,787	196,175	176,224	166,488
Tangible Book Value Per Share	36215.42	36614.39	35355.57	32142.19	28873.32	27278.10
Land	-	4,346	4,346	4,346	9,343	9,343
Buildings	-	30,472	30,472	30,472	30,445	30,445
Machinery	-	30,703	29,435	24,791	23,856	24,141
Construction In Progress	-	389.96	1,836	1,174	45.73	4.03